Nuwellis (NUWE) Retained Earnings (2011 - 2026)
Nuwellis' (NUWE) quarterly Retained Earnings came in at -$325.7 million in Q2 2026, down 3.59% on a YoY basis from -$337.8 million in Q2 2025, and down 200.68% quarter-over-quarter from $323.5 million in Q1 2026.
Analysis
Nuwellis (NUWE) Retained Earnings (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Retained Earnings for 16 consecutive years, with -$325.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings fell 3.59% year-over-year to -$325.7 million; the trailing twelve-month figure through Jun 2026 stood at -$325.7 million (down 3.59% YoY), and the FY2025 full-year result was $318.9 million, up 4.44% from the prior year.
- Retained Earnings declined to -$325.7 million in Q2 2026 per NUWE's latest filing, from $323.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $323.5 million in Q1 2026 and bottomed at -$325.7 million in Q2 2026.
- Historically, Retained Earnings has averaged $194.5 million across 5 years, with a median of $289.9 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings surged 208.61% in 2022, then tumbled 203.4% in 2024.
- Over 5 years, Retained Earnings stood at $279.7 million in 2022, then increased by 3.9% to $290.6 million in 2023, then gained by 5.06% to $305.4 million in 2024, then grew by 4.44% to $318.9 million in 2025, then tumbled by 202.12% to -$325.7 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$325.7 million, $323.5 million, and $318.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -325.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -325.70 Mn |
| Mar 31, 2026 | 323.51 Mn |
| Dec 31, 2025 | 318.93 Mn |
| Sep 30, 2025 | 317.85 Mn |
| Jun 30, 2025 | -314.40 Mn |
| Mar 31, 2025 | 305.43 Mn |
| Dec 31, 2024 | 305.37 Mn |
| Sep 30, 2024 | 300.55 Mn |
| Jun 30, 2024 | -299.70 Mn |
| Mar 31, 2024 | 292.88 Mn |
| Dec 31, 2023 | 290.65 Mn |
| Sep 30, 2023 | 289.98 Mn |
| Jun 30, 2023 | 289.85 Mn |
| Mar 31, 2023 | 287.53 Mn |
| Dec 31, 2022 | 279.74 Mn |
| Sep 30, 2022 | 279.57 Mn |
| Jun 30, 2022 | 279.35 Mn |
| Mar 31, 2022 | 279.11 Mn |
| Dec 31, 2021 | 278.87 Mn |
| Sep 30, 2021 | -257.40 Mn |